(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Caesarstone Ltd., MicroStrategy, and Canadian Solar.

The three biggest losers today are Cyanotech Corporation, Rock, and iRobot.

Winners today

1. Caesarstone Ltd. (CSTE) – 14.08%

Caesarstone Ltd., together with its subsidiaries, develops, manufactures, and markets engineered quartz surfaces under the Caesarstone brand in the United States, Australia, Canada, Latin America, Asia, Israel, Europe, the Middle East, and Africa. The company's engineered quartz slabs are primarily used as kitchen countertops in the renovation and remodeling construction end markets, as well as in new buildings construction market. Its products are also used in other applications, such as vanity tops, wall panels, back splashes, floor tiles, stairs, furniture, and other interior and exterior surfaces that are used in various residential and non-residential applications. The company also offers porcelain products under the Lioli brand for flooring and cladding applications, as well as resells natural stones, and fabrication and installation accessories. It sells its products directly to fabricators, sub-distributors, and resellers; and indirectly through a network of independent distributors. The company was formerly known as Caesarstone Sdot Yam Ltd. and changed its name to Caesarstone Ltd. in June 2016. Caesarstone Ltd. was founded in 1987 and is headquartered in MP Menashe, Israel.

NASDAQ ended the session with Caesarstone Ltd. rising 14.08% to $5.67 on Wednesday, after three successive sessions in a row of gains. NASDAQ dropped 0.84% to $16,170.36, after three sequential sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Caesarstone Ltd. has a trailing twelve months EPS of $-3.13.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.8%.

Sales Growth

Caesarstone Ltd.’s sales growth for the current quarter is negative 15.9%.

Volatility

Caesarstone Ltd.’s last week, last month’s, and last quarter’s current intraday variation average was 8.08%, 1.44%, and 2.59%.

Caesarstone Ltd.’s highest amplitude of average volatility was 8.56% (last week), 3.35% (last month), and 2.59% (last quarter).

More news about Caesarstone Ltd..

2. MicroStrategy (MSTR) – 8.67%

MicroStrategy Incorporated provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally. It offers MicroStrategy ONE, which provides non-technical users with the ability to directly access novel and actionable insights for decision-making; and MicroStrategy Cloud for Government service, which offers always-on threat monitoring that meets the rigorous technical and regulatory needs of governments and financial institutions. The company also provides MicroStrategy Support that helps customers achieve their system availability and usage goals through highly responsive troubleshooting and assistance; MicroStrategy Consulting, which provides architecture and implementation services to help customers realize their desired results; and MicroStrategy Education that offers free and paid learning options. In addition, it engages in the development of bitcoin. The company offers its services through direct sales force and channel partners. It serves the U.S. government, state and local governments, and government agencies, as well as a range of industries, including retail, banking, technology, manufacturing, insurance, consulting, healthcare, telecommunications, and the public sector. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.

NASDAQ ended the session with MicroStrategy rising 8.67% to $1,566.00 on Wednesday while NASDAQ fell 0.84% to $16,170.36.

Earnings Per Share

As for profitability, MicroStrategy has a trailing twelve months EPS of $26.45.

PE Ratio

MicroStrategy has a trailing twelve months price to earnings ratio of 59.21. Meaning, the purchaser of the share is investing $59.21 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.17%.

More news about MicroStrategy.

3. Canadian Solar (CSIQ) – 7.89%

Canadian Solar Inc., together with its subsidiaries, designs, develops, manufactures, and sells solar ingots, wafers, cells, modules, and other solar power products. The company operates through two segments, Module and System Solutions (MSS), and Energy. The MSS segment engages in the design, development, manufacture, and sale of a range of solar power products, including standard solar modules, specialty solar products, and solar system kits that are a ready-to-install packages comprising inverters, racking systems, and other accessories. It also provides engineering, procurement, and construction; and operation and maintenance (O&M) services. This segment's energy solution products include solar inverters and energy storage systems for utility, commercial, residential, and specialty product applications. Its O&M services include inspections, repair, and replacement of plant equipment; and site management and administrative support services for solar power projects. The Energy segment engages in the development and sale of solar power projects; and operation of solar power plants and sale of electricity. As of January 31, 2020, this segment had a fleet of solar power plants in operation with an aggregate capacity of approximately 880.2 MWp. The company's primary customers include distributors, system integrators, project developers, and installers/EPC companies. Canadian Solar Inc. sells its products primarily under its Canadian Solar brand name; and on an OEM basis. It has operations in North America, South America, Europe, South Africa, the Middle East, Australia, Asia, and internationally. The company was founded in 2001 and is headquartered in Guelph, Canada.

NASDAQ ended the session with Canadian Solar jumping 7.89% to $18.74 on Wednesday, after two consecutive sessions in a row of gains. NASDAQ fell 0.84% to $16,170.36, after three successive sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Canadian Solar has a trailing twelve months EPS of $4.99.

PE Ratio

Canadian Solar has a trailing twelve months price to earnings ratio of 3.76. Meaning, the purchaser of the share is investing $3.76 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.1%.

Sales Growth

Canadian Solar’s sales growth is negative 24.6% for the current quarter and negative 11.8% for the next.

Volatility

Canadian Solar’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.93%, a negative 0.46%, and a positive 3.02%.

Canadian Solar’s highest amplitude of average volatility was 5.52% (last week), 2.82% (last month), and 3.02% (last quarter).

Yearly Top and Bottom Value

Canadian Solar’s stock is valued at $18.74 at 17:32 EST, way below its 52-week high of $45.29 and above its 52-week low of $17.08.

More news about Canadian Solar.

4. Aurora Cannabis (ACB) – 6.37%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

NYSE ended the session with Aurora Cannabis rising 6.37% to $6.76 on Wednesday, after two sequential sessions in a row of losses. NYSE fell 1.23% to $17,947.30, after three sequential sessions in a row of gains, on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-58.28.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -102.67%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aurora Cannabis’s stock is considered to be oversold (<=20).

More news about Aurora Cannabis.

5. Cyclacel Pharmaceuticals (CYCCP) – 5.87%

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase I clinical trial for the treatment of advanced leukemias. Its oncology development programs also comprise Sapacitabine, an orally available prodrug of CNDAC, which is a novel nucleoside analog. In addition, the company's oncology development programs include seliciclib, a CDK inhibitor. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. Cyclacel Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Berkeley Heights, New Jersey.

NASDAQ ended the session with Cyclacel Pharmaceuticals jumping 5.87% to $18.40 on Wednesday, after five consecutive sessions in a row of losses. NASDAQ fell 0.84% to $16,170.36, after three consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Cyclacel Pharmaceuticals has a trailing twelve months EPS of $-2.05.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -272.63%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jan 19, 2024, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 3.3%.

Moving Average

Cyclacel Pharmaceuticals’s value is under its 50-day moving average of $18.99 and way above its 200-day moving average of $15.20.

Volume

Today’s last reported volume for Cyclacel Pharmaceuticals is 2 which is 99.83% below its average volume of 1178.

Yearly Top and Bottom Value

Cyclacel Pharmaceuticals’s stock is valued at $18.40 at 17:32 EST, way below its 52-week high of $22.20 and way above its 52-week low of $5.25.

More news about Cyclacel Pharmaceuticals.

6. Cutera (CUTR) – 5.23%

Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women's intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, myQ, and skincare products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website cutera.com. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1988 and is headquartered in Brisbane, California.

NASDAQ ended the session with Cutera jumping 5.23% to $1.61 on Wednesday while NASDAQ fell 0.84% to $16,170.36.

Earnings Per Share

As for profitability, Cutera has a trailing twelve months EPS of $-5.76.

More news about Cutera.

7. Donegal Group (DGICB) – 4.74%

Donegal Group Inc., an insurance holding company, provides personal and commercial lines of property and casualty insurance to businesses and individuals in the Mid-Atlantic, Midwestern, New England, and southern states. It operates through four segments: Investment Function, Personal Lines of Insurance, and Commercial Lines of Insurance. The company offers private passenger automobile policies that provide protection against liability for bodily injury and property damage arising from automobile accidents, as well as protection against loss from damage to automobiles. It also offers homeowners policies, which provide coverage for damage to residences and their contents from a range of perils, including fire, lightning, windstorm, and theft; and liability of the insured arising from injury to other persons or their property. In addition, the company offers commercial automobile policies that provide protection against liability for bodily injury and property damage arising from automobile accidents and protection against loss from damage to automobiles owned by the insured; commercial multi-peril policies that provide protection to businesses against various perils, primarily combining liability and physical damage coverages; and workers' compensation policies, which provide benefits to employees for injuries sustained during employment. The company markets its insurance products through a network of approximately 2,400 independent insurance agencies. Donegal Group Inc. was founded in 1986 and is headquartered in Marietta, Pennsylvania.

NASDAQ ended the session with Donegal Group rising 4.74% to $13.49 on Wednesday, following the last session’s downward trend. NASDAQ dropped 0.84% to $16,170.36, after three sequential sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Donegal Group has a trailing twelve months EPS of $0.14.

PE Ratio

Donegal Group has a trailing twelve months price to earnings ratio of 96.36. Meaning, the purchaser of the share is investing $96.36 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.92%.

Moving Average

Donegal Group’s value is below its 50-day moving average of $13.89 and below its 200-day moving average of $13.93.

Volume

Today’s last reported volume for Donegal Group is 149 which is 85.87% below its average volume of 1055.

More news about Donegal Group.

8. Diodes Incorporated (DIOD) – 4.37%

Diodes Incorporated designs, manufactures, and supplies application-specific standard products in the discrete, logic, and analog and mixed-signal semiconductor markets worldwide. It primarily focuses on low pin count semiconductor devices with one or more active and/or passive components. The company offers discrete semiconductor products, such as MOSFET, TVS, and performance Schottky rectifiers; GPP bridges and retifiers performance Schottky diodes; Zener and performance Zener diodes, including tight tolerance and low operating current type; standard, fast, super-fast, and ultra-fast recovery rectifiers; bridge rectifiers; switching diodes; small signal bipolar and prebiased transistors; other MOSFETs; thyristor surge protection devices; and transient voltage suppressors. It also provides analog products comprising power management devices consisting of AC-DC and DC-DC converters, USB power switches, and low dropout and linear voltage regulators; linear devices, such as operational amplifiers and comparators, current monitors, voltage references, and reset generators; LED lighting drivers; audio amplifiers; and sensor products, including hall-effect sensors and motor drivers. The company offers mixed-signal products, such as high speed mux/demux products, digital switches, interfaces, redelivers, clock ICs, and packet switches; standard logic products comprising low-voltage complementary metal–oxide–semiconductor (CMOS) and high-speed CMOS devices; ultra-low power CMOS logic products and analog switches; multichip products and co-packaged discrete, analog, and mixed-signal silicon in miniature packages; silicon and silicon epitaxial wafers; and crystals and oscillators. It sells its products to the consumer electronics, computing, communications, industrial, and automotive markets through direct sales and marketing personnel, independent sales representatives, and distributors. The company was incorporated in 1959 and is headquartered in Plano, Texas.

NASDAQ ended the session with Diodes Incorporated jumping 4.37% to $72.42 on Wednesday while NASDAQ slid 0.84% to $16,170.36.

Earnings Per Share

As for profitability, Diodes Incorporated has a trailing twelve months EPS of $4.91.

PE Ratio

Diodes Incorporated has a trailing twelve months price to earnings ratio of 14.75. Meaning, the purchaser of the share is investing $14.75 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.6%.

Sales Growth

Diodes Incorporated’s sales growth is negative 34.7% for the present quarter and negative 30% for the next.

Yearly Top and Bottom Value

Diodes Incorporated’s stock is valued at $72.42 at 17:32 EST, way under its 52-week high of $97.37 and way above its 52-week low of $60.00.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 81.1% and a negative 71.1%, respectively.

More news about Diodes Incorporated.

9. iShares MSCI Emerging Markets Consumer Discrectionary Sector (EMDI) – 4.34%

NASDAQ ended the session with iShares MSCI Emerging Markets Consumer Discrectionary Sector jumping 4.34% to $46.16 on Wednesday while NASDAQ slid 0.84% to $16,170.36.

More news about iShares MSCI Emerging Markets Consumer Discrectionary Sector.

10. Barclays PLC (DLBS) – 3.64%

NASDAQ ended the session with Barclays PLC rising 3.64% to $3.25 on Wednesday, after five sequential sessions in a row of losses. NASDAQ dropped 0.84% to $16,170.36, after three sequential sessions in a row of gains, on what was a somewhat down trend exchanging session today.

More news about Barclays PLC.

Losers Today

1. Cyanotech Corporation (CYAN) – -13.75%

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant that is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company sells its products as packaged consumer products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.

NASDAQ ended the session with Cyanotech Corporation falling 13.75% to $0.34 on Wednesday, following the last session’s downward trend. NASDAQ fell 0.84% to $16,170.36, after three sequential sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Cyanotech Corporation has a trailing twelve months EPS of $-0.73.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -29.25%.

Volume

Today’s last reported volume for Cyanotech Corporation is 2707 which is 89.25% below its average volume of 25203.

Revenue Growth

Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 22.49M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Cyanotech Corporation’s EBITDA is -49.09.

Yearly Top and Bottom Value

Cyanotech Corporation’s stock is valued at $0.34 at 17:32 EST, way below its 52-week high of $1.16 and way higher than its 52-week low of $0.12.

More news about Cyanotech Corporation.

2. Rock (RKT) – -12.86%

Rocket Companies, Inc., a fintech holding company, provides mortgage lending, title and settlement services, and other financial technology services in the United States and Canada. It operates through two segments, Direct to Consumer and Partner Network. The company's solutions include Rocket Mortgage, a mortgage lender; Amrock that provides title insurance, property valuation, and settlement services; Rocket Homes, a home search platform and real estate agent referral network, which offers technology-enabled services to support the home buying and selling experience; and Rocket Loans, an online-based personal loans business. It also offers Core Digital Media, a online marketing platform in the mortgage and personal financial product sectors; Rocket Money, a personal finance app that helps clients manage every aspect of their financial lives; Lendesk, a software services company that provides a point of sale system for mortgage professionals and a loan origination system for private lenders; Rock Connections, a sales and support platform specializing in contact center services; and Rocket Innovation Studio that recruits and mentors top technology talent. In addition, the company originates, closes, sells, and services agency-conforming loans. Rocket Companies, Inc. was founded in 1985 and is headquartered in Detroit, Michigan. The company operates as a subsidiary of Rock Holdings Inc.

NYSE ended the session with Rock dropping 12.86% to $12.30 on Wednesday while NYSE dropped 1.23% to $17,947.30.

Earnings Per Share

As for profitability, Rock has a trailing twelve months EPS of $1.8.

PE Ratio

Rock has a trailing twelve months price to earnings ratio of 6.82. Meaning, the purchaser of the share is investing $6.82 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.65%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 133.3% and 500%, respectively.

Previous days news about Rock

• What makes red rock resorts (rrr) a strong momentum stock: buy now?. According to Zacks on Tuesday, 9 April, "Shares of Red Rock Resorts have increased 23.48% over the past quarter, and have gained 41.07% in the last year. ", "Given these factors, it shouldn’t be surprising that RRR is a #2 (Buy) stock and boasts a Momentum Score of A. If you’re looking for a fresh pick that’s set to soar in the near-term, make sure to keep Red Rock Resorts on your short list."
• Red rock resorts (rrr) moves to buy: rationale behind the upgrade. According to Zacks on Tuesday, 9 April, "Red Rock Resorts (RRR Quick QuoteRRR – Free Report) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). ", "For Red Rock Resorts, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company’s underlying business. "

More news about Rock.

3. iRobot (IRBT) – -9.98%

iRobot Corporation designs, builds, and sells robots and home innovation products in the United States, Europe, the Middle East, Africa, Japan, and internationally. The company offers floor care products, including Roomba floor vacuuming robots; Roomba accessories and consumables, such as the Clean Base Automatic Dirt Disposal, replacement dirt disposal bags for the Clean Base, filters, brushes, and batteries; Braava family of automatic floor mopping robots; and Braava accessories and consumables, which include cleaning solution, washable and disposable mopping pads, replacement tanks, and batteries, as well as subscription services. It also provides Root robots for coding, discovery, and play; Roomba Combo mopping and vacuuming robot; and accessories, including robot vacuum and mop, handheld vacuum, and air purifier, educational coding robot, and accessory bundles. The company sells its products through chain stores and other national retailers, value- added distributors, and resellers, as well as through its website and app, and e-commerce websites. iRobot Corporation was incorporated in 1990 and is headquartered in Bedford, Massachusetts.

NASDAQ ended the session with iRobot dropping 9.98% to $9.20 on Wednesday while NASDAQ slid 0.84% to $16,170.36.

Class action filed against irobot corporation (irbt) – May 7, 2024 deadline to join – contact levi & korsinskyIf you suffered a loss in iRobot stock during the relevant time frame – even if you still hold your shares – go to https://zlk.com/pslra-1/irobot-lawsuit-submission-form?prid=75000&wire=1 to learn about your rights to seek a recovery. , THE LAWSUIT: A class action securities lawsuit was filed against iRobot Corporation that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between August 5, 2022 and January 26, 2024.

Earnings Per Share

As for profitability, iRobot has a trailing twelve months EPS of $-11.01.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4%.

Volatility

iRobot’s last week, last month’s, and last quarter’s current intraday variation average was a positive 7.01%, a negative 0.20%, and a positive 4.48%.

iRobot’s highest amplitude of average volatility was 7.01% (last week), 4.64% (last month), and 4.48% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

iRobot’s EBITDA is 0.38.

Moving Average

iRobot’s worth is way under its 50-day moving average of $19.53 and way below its 200-day moving average of $33.71.

Previous days news about iRobot

• Irobot corporation sued for securities law violations – investors should contact levi & korsinsky for more information – IRBT. According to Business Insider on Tuesday, 9 April, "If you suffered a loss in iRobot stock during the relevant time frame – even if you still hold your shares – go to https://zlk.com/pslra-1/irobot-lawsuit-submission-form?prid=74841&wire=1 to learn about your rights to seek a recovery. ", "NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your iRobot Corporation (NASDAQ:IRBT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:"

More news about iRobot.

4. Restoration Hardware Holdings (RH) – -9.77%

RH, together with its subsidiaries, operates as a retailer in the home furnishings market. The company offers products in various categories, including furniture, lighting, textiles, bathware, décor, outdoor and garden, baby, child, and teen furnishings. It provides its products through rh.com, rhbabyandchild.com, rhteen.com, rhmodern.com, and waterworks.com online channels, as well as operates RH Galleries, RH outlet stores, RH Guesthouse, and Waterworks showrooms in the United States, Canada, the United Kingdom, and Germany. The company was formerly known as Restoration Hardware Holdings, Inc. and changed its name to RH in January 2017. RH was incorporated in 2011 and is headquartered in Corte Madera, California.

NYSE ended the session with Restoration Hardware Holdings sliding 9.77% to $260.48 on Wednesday while NYSE slid 1.23% to $17,947.30.

Earnings Per Share

As for profitability, Restoration Hardware Holdings has a trailing twelve months EPS of $5.92.

PE Ratio

Restoration Hardware Holdings has a trailing twelve months price to earnings ratio of 44. Meaning, the purchaser of the share is investing $44 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.44%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Restoration Hardware Holdings’s EBITDA is 91.66.

Volume

Today’s last reported volume for Restoration Hardware Holdings is 1778870 which is 160.42% above its average volume of 683054.

More news about Restoration Hardware Holdings.

5. TrueBlue (TBI) – -9.2%

TrueBlue, Inc., together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries. The PeopleManagement segment offers contingent, on-site industrial staffing, and commercial driver services, which includes on-site management and recruitment for the contingent industrial workforce of manufacturing, warehousing, and distribution facilities; and recruitment and management of contingent and dedicated commercial drivers to the transportation and distribution industries under the Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands. The company PeopleScout segment provides recruitment process outsourcing, talent advisory services, and managed service provider solutions including sourcing, screening, hiring, and onboarding services; operates Affinix, a technology platform for sourcing, screening, and delivering a permanent workforce to its clients; talent advisory services, such as employer branding, recruitment marketing, talent insights, diversity, equity and inclusion consulting, candidate assessment, and talent acquisition strategy consulting services; and contingent labor programs including vendor selection, performance management, compliance monitoring, and risk management. TrueBlue, Inc. was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. The company was incorporated in 1985 and is headquartered in Tacoma, Washington.

NYSE ended the session with TrueBlue sliding 9.2% to $10.86 on Wednesday, after two sequential sessions in a row of gains. NYSE fell 1.23% to $17,947.30, after three successive sessions in a row of gains, on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, TrueBlue has a trailing twelve months EPS of $-0.45.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.97%.

Volume

Today’s last reported volume for TrueBlue is 384542 which is 16.9% below its average volume of 462765.

Yearly Top and Bottom Value

TrueBlue’s stock is valued at $10.86 at 17:32 EST, way under its 52-week high of $19.06 and above its 52-week low of $10.15.

More news about TrueBlue.

6. Flushing Financial Corporation (FFIC) – -8.36%

Flushing Financial Corporation operates as the bank holding company for Flushing Bank that provides banking products and services primarily to consumers, businesses, and governmental units. It offers various deposit products, including checking and savings accounts, money market accounts, demand accounts, NOW accounts, and certificates of deposit. The company also provides mortgage loans secured by multi-family residential, commercial real estate, one-to-four family mixed-use property, one-to-four family residential property, and commercial business loans; construction loans; small business administration loans and other small business loans; mortgage loan surrogates, such as mortgage-backed securities; and consumer loans, including overdraft lines of credit, as well as the United States government securities, corporate fixed-income securities, and other marketable securities. In addition, it offers banking services to public municipalities comprising counties, cities, towns, villages, school districts, libraries, fire districts, and various courts. As of December 31, 2021, the company operated 24 full-service offices located in the New York City boroughs of Queens, Brooklyn, and Manhattan; and in Nassau and Suffolk County, New York, as well as an Internet branch. Flushing Financial Corporation was founded in 1929 and is based in Uniondale, New York.

NASDAQ ended the session with Flushing Financial Corporation falling 8.36% to $11.07 on Wednesday, following the last session’s downward trend. NASDAQ fell 0.84% to $16,170.36, after three sequential sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Flushing Financial Corporation has a trailing twelve months EPS of $0.96.

PE Ratio

Flushing Financial Corporation has a trailing twelve months price to earnings ratio of 11.53. Meaning, the purchaser of the share is investing $11.53 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.26%.

Yearly Top and Bottom Value

Flushing Financial Corporation’s stock is valued at $11.07 at 17:32 EST, way below its 52-week high of $18.00 and way above its 52-week low of $9.28.

More news about Flushing Financial Corporation.

7. Esperion Therapeutics (ESPR) – -7.92%

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

NASDAQ ended the session with Esperion Therapeutics dropping 7.92% to $2.79 on Wednesday, after two sequential sessions in a row of losses. NASDAQ fell 0.84% to $16,170.36, after three consecutive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Esperion Therapeutics has a trailing twelve months EPS of $-2.03.

Moving Average

Esperion Therapeutics’s worth is way above its 50-day moving average of $2.49 and way above its 200-day moving average of $1.75.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Esperion Therapeutics’s EBITDA is -11.85.

More news about Esperion Therapeutics.

8. Pacific Biosciences of California (PACB) – -7.76%

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

NASDAQ ended the session with Pacific Biosciences of California dropping 7.76% to $3.33 on Wednesday while NASDAQ fell 0.84% to $16,170.36.

Earnings Per Share

As for profitability, Pacific Biosciences of California has a trailing twelve months EPS of $-1.21.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.53%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 25% and 7.1%, respectively.

Sales Growth

Pacific Biosciences of California’s sales growth for the current quarter is 46.2%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 113.3%, now sitting on 200.52M for the twelve trailing months.

More news about Pacific Biosciences of California.

9. Peloton (PTON) – -7.59%

Peloton Interactive, Inc. operates interactive fitness platform in North America and internationally. The company offers connected fitness products with touchscreen that streams live and on-demand classes under the Peloton Bike, Peloton Bike+, Peloton Tread, Peloton Tread+, Peloton Guide, and Peloton Row names. The company markets and sells its interactive fitness products directly through its retail showrooms and at onepeloton.com. Peloton Interactive, Inc. was founded in 2012 and is headquartered in New York, New York.

NASDAQ ended the session with Peloton dropping 7.59% to $3.65 on Wednesday while NASDAQ slid 0.84% to $16,170.36.

Earnings Per Share

As for profitability, Peloton has a trailing twelve months EPS of $-2.44.

Revenue Growth

Year-on-year quarterly revenue growth declined by 6.2%, now sitting on 2.73B for the twelve trailing months.

Moving Average

Peloton’s value is way below its 50-day moving average of $5.18 and way under its 200-day moving average of $6.20.

More news about Peloton.

10. First Foundation (FFWM) – -7.46%

First Foundation Inc., through its subsidiaries, provides personal banking, business banking, and private wealth management services in the United States. It operates through two segments, Banking and Wealth Management. The company offers a range of bank deposit products, including personal and business checking accounts, savings accounts, interest-bearing negotiable order of withdrawal accounts, money market accounts, and time certificate of deposits; and loan products consisting of multifamily and single family residential real estate loans, commercial real estate loans, and commercial term loans and line of credits, as well as consumer loans, such as personal installment loans and line of credits, and home equity line of credits. It also provides various specialized services comprising trust services, internet and mobile banking, remote deposit capture services, merchant credit card services, ATM cards, Visa debit cards, and business sweep accounts, as well as insurance brokerage services and equipment financing solutions. In addition, the company offers investment management and financial planning services; treasury management services; advisory and coordination services in the areas of estate planning, retirement planning, and charitable and business ownership issues; and financial, investment, and economic advisory and related services. Further, it provides support services, including the processing and transmission of financial and economic data for charitable organizations. The company operates through a network of 28 branch offices and 3 loan production offices in California, Nevada, Texas, and Hawaii. First Foundation Inc. was founded in 1985 and is headquartered in Dallas, Texas.

NASDAQ ended the session with First Foundation sliding 7.46% to $6.82 on Wednesday, after two consecutive sessions in a row of gains. NASDAQ dropped 0.84% to $16,170.36, after three successive sessions in a row of gains, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, First Foundation has a trailing twelve months EPS of $-3.53.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -19.33%.

Sales Growth

First Foundation’s sales growth for the current quarter is negative 26.9%.

Moving Average

First Foundation’s value is way under its 50-day moving average of $7.87 and below its 200-day moving average of $7.07.

More news about First Foundation.

Stay up to date with our winners and losers daily report